Tubulozole is a stereospecific microtubule inhibitor. Tests show the compound to have distinct antineoplastic properties in vivo by prolonging the median survival time of neoplasms: MO4 sarcoma, L1210 leukemia and TA3 carcinoma. Activity of tubulazole resides in the cis isomer, while the trans isomer has no effect at all.
The effects of tubulazole, a new synthetic microtubule inhibitor on experimental neoplasms: R. Van Ginckel, et al.; Eur. J. Canc. Clin. Oncol. 20, 99 (1984) Effects of tubulozole on the microtubule system of cells in culture and in vivo: G.M.A. Geuens, et al.; Cancer Res. 45, 733 (1985)